2026 ISH Global Hypertension Practice Guidelines

Featured image for the 2026 ISH Global Hypertension Practice Guidelines, featuring a world map, red heart with an ECG waveform, and a blood pressure gauge, representing global hypertension diagnosis and management.

What are the "2026 ISH Global Hypertension Practice Guidelines"?

The 2026 ISH Global Hypertension Practice Guidelines provide updated, evidence-informed recommendations for screening, diagnosing, and treating hypertension. Designed for healthcare professionals worldwide, they cover blood pressure measurement, cardiovascular risk assessment, lifestyle interventions, antihypertensive medications, resistant hypertension, comorbidities, and practical strategies to improve hypertension control across different healthcare settings.

Introduction

Hypertension remains one of the most important global public health challenges, contributing substantially to cardiovascular disease, stroke, chronic kidney disease, and premature mortality. Despite the availability of effective antihypertensive medications and well-established treatment strategies, achieving adequate blood pressure control continues to be difficult in many healthcare systems.

For physicians and other healthcare professionals, keeping up with evolving hypertension recommendations is essential for delivering appropriate, effective, and individualized patient care.

The 2026 International Society of Hypertension Global Hypertension Practice Guidelines address this challenge by providing updated recommendations for the screening, diagnosis, evaluation, and management of hypertension. Developed by the International Society of Hypertension (ISH), these guidelines aim to make contemporary hypertension care more accessible, practical, and adaptable to different healthcare environments.

Unlike highly specialized publications that concentrate on complex hypertension disorders, this guideline document emphasizes the everyday clinical decisions encountered by healthcare professionals managing patients with elevated blood pressure.

One of its most important objectives is to bridge the gap between medical evidence and its implementation in routine clinical practice. It considers the needs of both high-resource and low-resource healthcare settings, recognizing that hypertension management must be practical, affordable, and achievable across different populations.

The 2026 edition also introduces important changes involving standardized blood pressure measurement, home blood pressure monitoring, treatment thresholds, cardiovascular risk assessment, medication adherence, and newer pharmacological treatment options.

This makes the publication particularly relevant to medical students, interns, residents, general practitioners, cardiologists, nephrologists, internal medicine specialists, and other healthcare professionals involved in cardiovascular prevention and hypertension management.

Book Overview

The following information is available from the publication.

Category

Details

Full title

2026 International Society of Hypertension Global Hypertension Practice Guidelines

Authors

George S. Stergiou, Kazuomi Kario, Dagnovar Aristizabal, Hind Beheiry, Myeong-Chan Choe, and colleagues

Edition

2026 guidelines

Publisher

Wolters Kluwer Health, LLC

Journal

Journal of Hypertension

Publication year

2026

Volume

44

Issue

12

Pages

2157–2188

DOI

10.1097/HJH.0000000000004451

Medical specialty

Hypertension, cardiology, cardiovascular medicine, and internal medicine

Intended audience

Healthcare professionals, medical students, residents, physicians, and researchers

The publication was developed by an International Society of Hypertension Guidelines Committee consisting of 13 current ISH Council members from 12 countries. It was also reviewed by 24 international experts representing 15 countries across all five continents.

The document is a clinical practice guideline rather than a conventional medical textbook. Its main purpose is to translate existing evidence and recommendations into a practical framework for managing hypertension worldwide.

WHAT THIS BOOK COVERS

The 2026 ISH guidelines provide a comprehensive overview of the essential principles of hypertension management, from initial screening to long-term treatment and follow-up.

The following are the major clinical areas addressed.

1. Introduction and the Global Burden of Hypertension

The opening section explains the worldwide impact of elevated blood pressure and its contribution to cardiovascular and renal complications.

It discusses the increasing prevalence of hypertension, differences between high-income and low- and middle-income countries, and the persistent challenges associated with achieving adequate blood pressure control.

An important message is that the main obstacle is not simply the absence of effective medications or clinical knowledge. The implementation of existing recommendations in everyday healthcare settings remains a major challenge.

The guidelines therefore emphasize practical strategies that can improve hypertension detection, treatment adherence, and long-term cardiovascular outcomes.

2. Definition and Classification of Hypertension

The guidelines explain how hypertension is defined and classified using standardized office blood pressure measurements.

An important update is the introduction of the term "elevated BP," referring to systolic blood pressure of 130–139 mmHg and/or diastolic blood pressure of 80–89 mmHg.

The adult classification includes:

  • Normal blood pressure: below 130/80 mmHg.
  • Elevated blood pressure: 130–139 mmHg systolic and/or 80–89 mmHg diastolic.
  • Grade 1 hypertension: 140–159 mmHg systolic and/or 90–99 mmHg diastolic.
  • Grade 2 hypertension: 160 mmHg or higher systolic and/or 100 mmHg or higher diastolic.

The document emphasizes that hypertension should generally be confirmed through standardized measurements across at least two visits rather than relying on a single casual office reading.

This section provides an important foundation for understanding subsequent diagnostic and therapeutic recommendations.

3. Blood Pressure Measurement and Diagnosis

Accurate blood pressure measurement is essential for diagnosing hypertension and evaluating treatment effectiveness.

The 2026 guidelines place considerable emphasis on standardized measurement techniques and distinguish between standardized office blood pressure (sOBP) and standardized home blood pressure monitoring (sHBPM).

The section covers:

  • Systematic screening for hypertension.
  • Standardized office blood pressure measurement.
  • Appropriate cuff selection and positioning.
  • Home blood pressure monitoring.
  • Twenty-four-hour ambulatory blood pressure monitoring.
  • White-coat hypertension.
  • Masked hypertension.
  • Nocturnal hypertension.
  • Blood pressure variability.
  • Alternative and emerging blood pressure measurement technologies.

One particularly important recommendation is the use of standardized home blood pressure monitoring as the main method for diagnosis and management when reliable monitoring is possible.

The guidelines also explain that casual office and home measurements may produce misleading results and should not replace standardized measurement protocols.

For clinical practice, this section is particularly useful because incorrect measurement techniques can lead to misclassification, unnecessary treatment escalation, or failure to identify uncontrolled hypertension.

4. Clinical Evaluation and Diagnostic Tests

This section describes the initial clinical assessment of patients with hypertension.

It emphasizes obtaining a detailed medical and family history, evaluating cardiovascular risk factors, identifying symptoms of hypertension-mediated organ damage, and considering possible secondary causes.

The recommended assessment includes:

  • Previous blood pressure measurements and hypertension history.
  • Current and previous antihypertensive medications.
  • Medication adherence and adverse effects.
  • Family history of cardiovascular disease.
  • Smoking, alcohol consumption, dietary habits, and physical activity.
  • Symptoms suggesting cardiac, neurological, or renal complications.
  • Physical examination and appropriate laboratory investigations.

The guidelines also discuss investigations such as serum creatinine, estimated glomerular filtration rate, electrolytes, lipid profile, fasting glucose, urinalysis, and electrocardiography.

Additional imaging investigations are considered when clinically indicated.

5. Cardiovascular Risk Factors and Risk Estimation

Hypertension rarely occurs in isolation. Many patients have additional cardiovascular risk factors that substantially increase their likelihood of developing complications.

This section explains how clinicians should evaluate overall cardiovascular risk rather than focusing exclusively on blood pressure values.

Important risk factors include:

  • Diabetes mellitus.
  • Obesity and overweight.
  • Dyslipidemia.
  • Chronic kidney disease.
  • Smoking.
  • Obstructive sleep apnea.
  • Hyperuricemia.
  • Physical inactivity.
  • Unhealthy dietary habits.
  • Family history of premature cardiovascular disease.

The guidelines discuss cardiovascular risk estimation using appropriate regional risk assessment tools.

They also explain why the presence of hypertension-mediated organ damage or established cardiovascular and renal disease can change a patient's risk classification and influence treatment decisions.

6. Hypertension-Mediated Organ Damage

Long-standing uncontrolled hypertension can cause damage to multiple organs, often before obvious clinical symptoms develop.

The guidelines explain the importance of identifying hypertension-mediated organ damage (HMOD) involving:

  • Heart.
  • Brain.
  • Kidneys.
  • Arteries.
  • Eyes.

Examples include left ventricular hypertrophy, chronic kidney disease, albuminuria, cognitive impairment, carotid atherosclerosis, and peripheral arterial disease.

The document discusses the appropriate use of electrocardiography, echocardiography, renal investigations, vascular imaging, and other diagnostic techniques.

This section is particularly valuable for understanding why hypertension management involves more than achieving a specific blood pressure reading.

7. Treatment of Hypertension

The treatment section is one of the most clinically important parts of the publication.

It covers lifestyle interventions, treatment initiation, blood pressure targets, pharmacological management, emerging drug therapies, renal denervation, and medication adherence.

Lifestyle modifications

The guidelines recommend lifestyle changes as an important component of hypertension prevention and treatment.

They discuss dietary modifications, salt reduction, physical activity, weight management, and other healthy lifestyle measures.

Combined lifestyle interventions can reduce systolic blood pressure by more than 10 mmHg, depending on baseline blood pressure and adherence.

Pharmacological treatment

The document explains when antihypertensive medications should be initiated and how treatment intensity should be selected.

For most patients with confirmed hypertension, the guidelines recommend initiating treatment using a two-drug single-pill combination, with an essential target below 140/90 mmHg and an optimal target below 130/80 mmHg.

For most individuals with elevated blood pressure, treatment is also recommended under the optimal-care approach, generally using monotherapy or a low-dose two-drug combination in selected high-risk individuals.

The publication discusses the advantages of combination therapy, particularly when multiple medications are needed to achieve recommended blood pressure targets.

New pharmacological options

An important feature of the 2026 guidelines is the discussion of newer antihypertensive treatment options, including:

  • Aldosterone synthase inhibitors.
  • Endothelin receptor antagonists.
  • Non-steroidal mineralocorticoid receptor antagonists.
  • Angiotensinogen-targeting small interfering RNA therapies.

The document discusses their mechanisms, potential clinical applications, availability, and important safety considerations.

Renal denervation

Renal denervation is discussed as a potential option for selected patients with difficult-to-control or resistant hypertension.

The guidelines emphasize appropriate patient selection, exclusion of pseudo-resistance, assessment of renal function, and referral to experienced hypertension centres.

Medication adherence

Another important focus is the identification and management of non-adherence to antihypertensive therapy.

The guidelines describe practical approaches such as simplified medication regimens, single-pill combinations, once-daily dosing, home blood pressure monitoring, reminder systems, and multidisciplinary follow-up.

8. Hypertension With Comorbidities and Complications

This section addresses the management of hypertension in patients with associated medical conditions.

The clinical situations discussed include:

  • Hypertension and type 2 diabetes.
  • Hypertension and chronic kidney disease.
  • Hypertension and coronary artery disease.
  • Hypertension and stroke.
  • Hypertension and dementia.
  • Hypertension and heart failure.
  • Hypertension and atrial fibrillation.
  • Hypertension and chronic obstructive pulmonary disease.
  • Hypertension and obstructive sleep apnoea.
  • Hypertension and dyslipidaemia.
  • Hypertension and obesity.
  • Hypertension and HIV/AIDS.

The recommendations emphasize the importance of individualized management, considering the patient's associated diseases, cardiovascular risk, renal function, and medication requirements.

This section is particularly useful for internal medicine physicians and specialists managing patients with multiple chronic conditions.

9. Specific Clinical Circumstances

The guidelines also address situations requiring additional investigation or more specialized management.

These include:

  • Difficult-to-control hypertension.
  • Resistant hypertension.
  • Secondary hypertension.
  • Hypertension in pregnancy.
  • Hypertension in children.
  • Hypertension in older adults and individuals with frailty.
  • Circumstances requiring emergency or expert referral.

The publication discusses how to identify true resistant hypertension and distinguish it from apparent treatment resistance caused by poor adherence, inaccurate measurements, white-coat effects, or inadequate treatment regimens.

It also highlights the importance of investigating secondary causes such as primary aldosteronism, renal parenchymal disease, renovascular hypertension, and obstructive sleep apnoea.

10. Ethnic and Regional Differences in Hypertension

Hypertension prevalence, cardiovascular risk, treatment response, and healthcare access differ between populations.

This section discusses ethnic and regional considerations in hypertension management, recognizing the influence of genetic, environmental, cultural, socioeconomic, and healthcare-related factors.

It includes considerations relating to different population groups and migrant populations.

The overall objective is to encourage clinically appropriate treatment while recognizing that healthcare recommendations must be implemented in the context of local population characteristics.

11. Implementation of Hypertension Care

An important theme throughout the guidelines is the need to improve the implementation of effective hypertension management.

The publication introduces the ISH OnTheGo initiative, an AI-powered web application designed for smartphones and desktop computers to support healthcare professionals in applying the guidelines.

It also emphasizes task-sharing and the involvement of non-physician healthcare professionals (NPHPS), according to their prescribing rights and access to physicians.

The broader implementation approach includes multidisciplinary care, community-based screening, digital health technologies, improved medication adherence, and structured follow-up.

This makes the guidelines relevant not only to individual clinicians but also to healthcare educators, administrators, and professionals involved in public health programmes.

Key Features

The major educational and clinical features of the 2026 ISH guidelines include:

  • Internationally developed hypertension recommendations involving experts from multiple countries.
  • Updated classification of elevated blood pressure and hypertension.
  • Detailed standardized office blood pressure measurement recommendations.
  • Emphasis on standardized home blood pressure monitoring.
  • Practical guidance on ambulatory blood pressure monitoring.
  • Discussion of white-coat, masked, and nocturnal hypertension.
  • Comprehensive cardiovascular risk assessment.
  • Evaluation of hypertension-mediated organ damage.
  • Updated recommendations for lifestyle and pharmacological treatment.
  • Discussion of emerging antihypertensive medications.
  • Guidance on resistant and secondary hypertension.
  • Recommendations for hypertension associated with common comorbidities.
  • Consideration of ethnic and regional differences.
  • Practical approaches to improving medication adherence.
  • Strategies for implementing hypertension care in different healthcare environments.
  • Recommendations involving multidisciplinary and non-physician healthcare professionals.
  • Introduction of the ISH OnTheGo implementation initiative.

Who Should Read This Book?

Medical Students

Medical students can use these guidelines to understand the fundamental principles of hypertension classification, diagnosis, cardiovascular risk assessment, and treatment.

The document also provides a useful overview of important clinical concepts encountered during internal medicine and cardiology rotations.

Medical Interns and Residents

Interns and residents can benefit from the practical recommendations on blood pressure measurement, diagnostic evaluation, medication selection, treatment targets, and follow-up.

The sections on resistant hypertension and secondary causes are particularly relevant to clinical rotations and patient assessment.

General Practitioners and Family Physicians

Primary care physicians are among the main intended users of practical hypertension recommendations.

The guidelines provide an approach to screening, diagnosis, initial treatment, long-term monitoring, and cardiovascular risk reduction.

Cardiologists

Cardiologists may find the updated recommendations useful when managing patients with hypertension and associated cardiovascular diseases, including coronary artery disease, heart failure, atrial fibrillation, and previous stroke.

Nephrologists

The discussion of chronic kidney disease, albuminuria, renal function, antihypertensive treatment, and resistant hypertension is particularly relevant to nephrology practice.

Medical Exam Candidates

The classification of hypertension, diagnostic thresholds, measurement techniques, treatment strategies, and complications provide useful revision material for postgraduate examinations.

However, the publication is primarily a clinical practice guideline rather than a dedicated examination preparation textbook.

Why This Book Is Useful

1. Strong Clinical Relevance

Hypertension is encountered across almost every medical specialty.

The guidelines provide a structured approach to clinical decision-making, helping healthcare professionals understand how to evaluate blood pressure, identify cardiovascular risk, and select appropriate treatment strategies.

2. Evidence-Informed Recommendations

The guidelines synthesize recommendations from recently published clinical guidelines and adapt them into a unified international framework.

The committee systematically examined areas of agreement and disagreement between existing recommendations rather than conducting an entirely new evidence review.

This approach makes the publication useful for understanding how contemporary hypertension recommendations are organized and implemented.

3. Practical Applications

The emphasis on standardized blood pressure measurement, home monitoring, treatment initiation, and follow-up gives the publication practical value.

It addresses decisions that healthcare professionals frequently encounter when assessing and managing patients with hypertension.

4. Usefulness for Postgraduate Learning

The document covers essential hypertension topics relevant to internal medicine, cardiology, nephrology, and general medical practice.

It can support postgraduate learning through its classification tables, diagnostic recommendations, treatment algorithms, and discussions of important clinical scenarios.

5. Efficient Clinical Reference

The publication uses structured recommendations, tables, and figures to communicate important information.

Rather than requiring readers to navigate an extensive textbook, it provides a focused clinical framework that can be consulted during study or clinical practice.

6. Global Healthcare Perspective

One of its distinctive strengths is the consideration of both high-resource and low-resource healthcare environments.

The recommendations recognize that access to medications, diagnostic technologies, and specialist services varies significantly across countries.

This international perspective makes the publication relevant to healthcare professionals working in diverse clinical settings.

Table of Contents Overview

The publication is organized into numbered clinical sections rather than conventional textbook chapters.

Its major sections include:

  1. Introduction: The global burden of hypertension and the objectives of the 2026 ISH guidelines.
  2. Definition of Hypertension: Diagnostic definitions and adult blood pressure classification.
  3. Blood Pressure Measurement and Diagnosis of Hypertension: Screening, standardized office measurements, home monitoring, ambulatory monitoring, and hypertension phenotypes.
  4. Clinical Evaluation and Diagnostic Tests: Medical history, physical examination, laboratory investigations, and imaging.
  5. Cardiovascular Risk Factors and Risk Estimation: Identification and assessment of additional cardiovascular risk factors.
  6. Hypertension-Mediated Organ Damage: Assessment of cardiac, cerebral, renal, vascular, and ocular complications.
  7. Treatment of Hypertension: Lifestyle modifications, pharmacological treatment, new drug options, renal denervation, and medication adherence.
  8. Hypertension With Comorbidities and Complications: Management in patients with diabetes, CKD, cardiovascular disease, and other associated conditions.
  9. Specific Circumstances: Resistant hypertension, secondary hypertension, and special clinical populations.
  10. Ethnic and Regional Differences in Hypertension: Population-related considerations in hypertension management.
  11. Implementation of Hypertension Care: Practical approaches to improving diagnosis, treatment, and healthcare delivery.

The publication also contains supporting tables, clinical figures, recommendations, and an extensive reference list.

Strengths of the Book

The 2026 International Society of Hypertension Global Hypertension Practice Guidelines have several important academic and clinical strengths.

International expert involvement

The participation of an international committee and reviewers from different countries gives the publication a broad global perspective.

Practical clinical organization

The guidelines address the major stages of hypertension care, from screening and diagnosis to treatment and long-term follow-up.

Updated diagnostic recommendations

The emphasis on standardized office and home blood pressure measurement is particularly valuable for improving diagnostic accuracy.

Comprehensive treatment discussion

The publication covers conventional antihypertensive therapy alongside emerging pharmacological options and selected interventional approaches.

Attention to medication adherence

By recognizing non-adherence as a modifiable cardiovascular risk factor, the guidelines address an important reason for inadequate blood pressure control.

Consideration of comorbidities

The recommendations acknowledge that hypertension frequently coexists with diabetes, kidney disease, obesity, and cardiovascular conditions.

Global implementation perspective

The consideration of different healthcare resources and task-sharing strategies makes the recommendations relevant beyond specialist hypertension centres.

Clear supporting material

The use of tables, figures, and treatment algorithms helps readers understand important diagnostic and therapeutic recommendations.

Limitations

Although the guidelines provide a valuable clinical framework, readers should understand their intended scope.

The authors explicitly state that the publication is not designed to provide highly detailed recommendations for hypertension specialists or cover the full spectrum of hypertension causes and management.

Other important considerations include:

  • The document focuses on practical recommendations relevant to most patients worldwide rather than providing an exhaustive textbook-level discussion of every hypertension disorder.
  • The committee synthesized recommendations from existing guidelines rather than conducting a completely new evidence review.
  • Some advanced investigations and newer treatment options may not be available in all healthcare systems.
  • Recommendations involving newer pharmacological treatments may depend on local regulatory approval, availability, and affordability.
  • The publication is a clinical practice guideline and should be interpreted alongside individual patient characteristics, clinical judgment, and applicable local recommendations.

These considerations reflect the publication's intended role as a practical global guideline rather than a comprehensive specialist reference textbook.

Comparison With Similar Books and Guidelines

The 2026 ISH guidelines belong to the broader field of international hypertension clinical practice recommendations.

They can be considered alongside other established hypertension guidelines, including European Society of Hypertension recommendations and American cardiovascular hypertension guidance.

However, the publication has a distinctive emphasis on global applicability and practical implementation across different healthcare environments.

Its approach gives particular attention to:

  • Adaptation of recommendations to high-resource and low-resource settings.
  • Standardized home blood pressure monitoring.
  • Practical treatment algorithms.
  • Medication adherence.
  • Multidisciplinary care and task-sharing.
  • International implementation strategies.

Unlike comprehensive hypertension textbooks, the ISH document provides concise, actionable clinical recommendations.

The publication does not include a direct head-to-head comparison with other guidelines. Therefore, it is more appropriate to view it as a complementary clinical reference rather than a replacement for detailed specialist textbooks or other regional guidelines.



Or: Link 2

FAQs

1. What are the 2026 International Society of Hypertension Global Hypertension Practice Guidelines?

They are updated international clinical practice recommendations developed by the International Society of Hypertension to guide the screening, diagnosis, evaluation, and treatment of hypertension in different healthcare settings worldwide.

2. Who developed the 2026 ISH Hypertension Guidelines?

The guidelines were developed by an International Society of Hypertension committee consisting of 13 current ISH Council members from 12 countries and reviewed by 24 international experts from 15 countries.

3. What are the major updates in the 2026 ISH guidelines?

Important updates include the introduction of the Elevated BP category, standardized office and home blood pressure terminology, greater emphasis on home blood pressure monitoring, treatment recommendations for elevated blood pressure, newer antihypertensive drug options, renal denervation considerations, and improved medication adherence strategies.

4. What blood pressure level is classified as elevated BP in the 2026 ISH guidelines?

Elevated blood pressure is defined as standardized office systolic blood pressure of 130–139 mmHg and/or diastolic blood pressure of 80–89 mmHg.

5. What is the recommended blood pressure target in the 2026 ISH guidelines?

For most patients receiving hypertension treatment, the essential standardized office blood pressure target is below 140/90 mmHg, while the optimal target is below 130/80 mmHg. Treatment targets should be individualized according to the patient's clinical circumstances.

6. Do the 2026 ISH guidelines discuss resistant hypertension?

Yes. They include recommendations for evaluating apparent and true resistant hypertension, excluding pseudo-resistance, investigating secondary causes, optimizing medication regimens, and considering renal denervation in selected patients.

7. Are the 2026 ISH guidelines useful for medical students and residents?

Yes. They provide a structured overview of hypertension classification, blood pressure measurement, diagnostic investigations, cardiovascular risk assessment, treatment strategies, and complications. They can be particularly useful for internal medicine and cardiology learning.

8. Do the 2026 ISH guidelines cover hypertension in patients with other medical conditions?

Yes. They discuss hypertension associated with diabetes, chronic kidney disease, coronary artery disease, stroke, heart failure, atrial fibrillation, obesity, obstructive sleep apnoea, and other clinical conditions.

Conclusion

The 2026 International Society of Hypertension Global Hypertension Practice Guidelines provide a valuable and updated clinical reference for healthcare professionals involved in the prevention, diagnosis, and management of hypertension.

Their major strength is the combination of contemporary recommendations with a practical approach to everyday clinical care. The publication addresses essential aspects of hypertension management, including accurate blood pressure measurement, cardiovascular risk assessment, identification of organ damage, lifestyle interventions, pharmacological treatment, and long-term medication adherence.

The updated recommendations concerning elevated blood pressure, standardized home monitoring, emerging antihypertensive therapies, and multidisciplinary hypertension care make this edition particularly relevant to modern clinical practice.

Medical students and residents can use it to strengthen their understanding of hypertension, while general practitioners, cardiologists, nephrologists, and other specialists can consult it when reviewing clinical management strategies.

Although it does not replace comprehensive specialist textbooks or detailed references on complex hypertension disorders, it offers a focused and internationally relevant framework for evidence-informed clinical practice.

For anyone seeking an updated understanding of hypertension diagnosis and treatment, the 2026 ISH Global Hypertension Practice Guidelines are a valuable addition to their medical reference collection.

Disclaimer

MedBook 4 Free does not own the copyrights to this video/book/software. We’re sharing this with our audience ONLY for educational purposes, and we strongly encourage visitors to purchase original, licensed software/books.

If the copyright owner wants us to remove this software/book, please contact us immediately. You can email [email protected] for all DMCA/removal requests.

Comments